A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This study is a multi-center, randomized, double-blind, placebo-controlled study. About 90 liver disease subjects with moderate or above pruritus are planned to be enrolled. They will be randomized to two dose groups (0.3 μg/kg and 0.6 μg/kg) and a placebo control group at a 1:1:1 ratio, with about 30 subjects in each group.
Epistemonikos ID: 600557f696aa07557e3aaa67b00fc0a6c9f7f27c
First added on: Dec 20, 2022